Lankau Consulting is an advisory and consulting firm which provides services to Executive Management and Boards of Directors within specialty pharma, biotech, pharma services, venture capital and private equity firms. We have expertise in strategic planning, due diligence, product/technology licensing assessments and negotiation, clinical development protocol assessment, commercialization strategies and implementation, management and financial assessments.
We also advise law firms by providing pharma industry background and expertise on industry related matters and providing expert opinions and testimony in litigation/arbitration cases, both in federal and state courts.
We specialize in providing strategic and operational support for executive teams, boards of directors, and investors in the pharmaceutical and biotechnology industries in areas of critical concern - delivering positive performance and building business valuation. We have over 30 years' experience in developing and commercializing pharmaceutical products, and we focus our expertise on supporting strategic and operational performance as well as your desired results.
Effective consultants do more than simply validate your existing strategies. They come to truly understand your business and its needs, develop alternatives to achieve those needs, and present you with options. First, we study your needs, your environment, your customers, and your dynamics. Then we dissect, strategize, and plan for changing your environment. Finally, we devise options to help you assess, revise and then implement your best approach to solving your business challenge. Results are what matter.
Our team has extensive experience working with multiple stakeholders in the pharma, biotech, and pharma services industries. These include relationships with:
all with unique needs and, at times, their own priorities. Integrating these needs by supporting development of win-win strategies for our clients is our expertise, no matter what the competing interests may be.